Drug intelligence / Profile preview

aloperine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intravenous, Rectal
01

Overview

Aloperine is a **quinolizidine alkaloid** primarily extracted from the roots of the plant *Sophora alopecuroides*. It is a natural product with documented biological activities including anti-inflammatory, antiviral, antitumor (anticancer), and immunomodulatory effects. Mechanistically, aloperine has been shown to inhibit various targets and pathways, such as PI3K/Akt, NF-κB, and Bcl-2 family proteins, depending on the disease model (notably in inflammation and cancers). It is not approved as a pharmaceutical but is researched as a bioactive lead compound in drug discovery for multiple disease indications.

Other names
4,5-dihydro-10,15-dimethylpyrido[1,2-a]quinolizidin-6-iumaloperin
02

Targets

BCL-2 (BCL-2 family)Ras/Extracellular signal-regulated kinase signaling pathway

Beyond the preview

Go deeper on aloperine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aloperine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call